Paper3497983
Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells.
Warner SJ and 2 others. J Immunol, 1987. Cited by 273 papers, by iCite.
Cite this record
ConductScience Library. Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells. Papers, record 3497983. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3497983
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells.
- PubMed
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endothelium | Major topic |
| Interleukin-1 | Major topic |
| Cells, Cultured | |
| Cycloheximide | |
| Gene Expression Regulation | |
| Hot Temperature | |
| Humans | |
| Indomethacin | |
| Monocytes | |
| Polymyxin B | |
| RNA, Messenger | |
| Recombinant Proteins | |
| Time Factors |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HL-34636 | NHLBI NIH HHS | United States | R01HL034636 | PubMed and NIH | NIH RePORTER |
| R37HL034636 | NIH | NIH RePORTER |
Cited by75
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 273 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39034937 | Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review. | Am J Med Open | 2024 | https://conductscience.org/library/papers/39034937 | PubMed |
| 37163428 | Atherosclerosis: The Involvement of Immunity, Cytokines and Cells in Pathogenesis, and Potential Novel Therapeutics. | Aging Dis | 2023 | https://conductscience.org/library/papers/37163428 | PubMed |
| 36847822 | Coenzyme Q0 defeats NLRP3-mediated inflammation, EMT/metastasis, and Warburg effects by inhibiting HIF-1α expression in human triple-negative breast cancer cells. | Arch Toxicol | 2023 | https://conductscience.org/library/papers/36847822 | PubMed |
| 36505497 | Determining distinct roles of IL-1α through generation of an IL-1α knockout mouse with no defect in IL-1β expression. | Front Immunol | 2022 | https://conductscience.org/library/papers/36505497 | PubMed |
| 35835255 | Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment. | J Allergy Clin Immunol | 2022 | https://conductscience.org/library/papers/35835255 | PubMed |
| 35327504 | Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review. | Biomedicines | 2022 | https://conductscience.org/library/papers/35327504 | PubMed |
| 35237956 | Key Roles of Inflammation in Atherosclerosis: Mediators Involved in Orchestrating the Inflammatory Response and Its Resolution in the Disease Along with Therapeutic Avenues Targeting Inflammation. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35237956 | PubMed |
| 33924019 | Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond. | Cells | 2021 | https://conductscience.org/library/papers/33924019 | PubMed |
| 33170943 | Inflammation in Coronary Atherosclerosis and Its Therapeutic Implications. | Cardiovasc Drugs Ther | 2022 | https://conductscience.org/library/papers/33170943 | PubMed |
| 32882706 | COVID-19 is, in the end, an endothelial disease. | Eur Heart J | 2020 | https://conductscience.org/library/papers/32882706 | PubMed |
| 32832913 | Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019. | Crit Care Explor | 2020 | https://conductscience.org/library/papers/32832913 | PubMed |
| 32046640 | Body fat percentage and CRP correlates with a composite score of vascular risk markers in healthy, young adults - The Lifestyle, Biomarkers, and Atherosclerosis (LBA) study. | BMC Cardiovasc Disord | 2020 | https://conductscience.org/library/papers/32046640 | PubMed |
| 32039025 | Understanding the Complexity of the Tumor Microenvironment in K-ras Mutant Lung Cancer: Finding an Alternative Path to Prevention and Treatment. | Front Oncol | 2019 | https://conductscience.org/library/papers/32039025 | PubMed |
| 31665239 | Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema. | Brain | 2019 | https://conductscience.org/library/papers/31665239 | PubMed |
| 31652822 | IL-1β and Statin Treatment in Patients with Myocardial Infarction and Diabetic Cardiomyopathy. | J Clin Med | 2019 | https://conductscience.org/library/papers/31652822 | PubMed |
| 31588428 | Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a review. | Cardiovasc Endocrinol Metab | 2019 | https://conductscience.org/library/papers/31588428 | PubMed |
| 30698710 | Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis. | Eur Heart J | 2019 | https://conductscience.org/library/papers/30698710 | PubMed |
| 29420212 | Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease. | Circ Res | 2018 | https://conductscience.org/library/papers/29420212 | PubMed |
| 29073957 | Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond. | J Am Coll Cardiol | 2017 | https://conductscience.org/library/papers/29073957 | PubMed |
| 28435302 | In situ detection of Chlamydia pneumoniae, C. trachomatis, and cytokines among cardiovascular diseased patients from the Amazon region of Brazil. | Infect Drug Resist | 2017 | https://conductscience.org/library/papers/28435302 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL1A | 3552 | PubTator's text mining | https://conductscience.org/library/genes/3552 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3497983
GET https://conductscience.org/api/papers/v1/3497983/cited_by?page=2